In honor of Hemp History Week, Nutritional Outlook spoke with John Roulac, founder and chief visionary officer at plant-based organic foods company Nutiva, about the current regulatory landscape for U.S. industrial hemp farming, and what’s next for the hemp category.
In honor of Hemp History Week, Josh Hendrix, director of business development for CBD supplier CV Sciences Inc., shared with us five lesser-known facts about the hemp plant.
Arjuna says the new European patent for its BCM-95 turmeric extract ingredient covers its specific “composition for use in treatment.”
In May, FDA sent warning letters to nutricosmetic supplements making sun protection health claims. What, if any, sun protection claims can nutricosmetic products make?
The meta-analysis found that folic acid and B vitamins have only minimal protective benefits for cardiovascular disease and stroke, respectively.
The gummies’ glyphosate residue–free designation guarantees that they have not been sprayed with and do not contain residues from the herbicide glyphosate.
NSF International will test Austrian Ski Federation athletes' supplements to reduce the risk of inadvertent doping in Olympic skiers.
FDA announced today that it sent warning letters to four makers of “sun protection” nutricosmetic ingestible supplements for making illegal drug claims related to UV protection and skin cancer.
Health Canada’s letter of no objection means that Deerland Enzymes & Probiotics’ DE111 strain is no longer a Novel Food and can now be sold as a food ingredient without the need for premarket notification.
Nutritional Outlook recently spoke with Ellen Schutt, GOED’s new executive director, about how, under her leadership, the organization plans to identify market opportunities to move the omega-3 category forward.
Shaheen Majeed, president, Sabinsa worldwide, spoke to Nutritional Outlook about how Sabinsa has navigated 30 years of regulatory change, and how the company plans to continue to deliver science-backed, innovative ingredients for a growing range of health categories.
HB 1195 has been sent to a study by the Massachusetts Joint Committee on Public Health, meaning that it will not be up for passage during this legislative session.
Balchem Corp. said that its VitaCholine line of choline chloride and choline bitartrate ingredients have been verified non-GMO by the Non-GMO Project.
This year’s Nutrition and Health Summit is scheduled to take place the day before the Healthplex Nutraceutical China (HNC) Expo.
Smaller firms have until January 1, 2021, to comply with labeling changes, while larger firms have until January 1, 2020.
Research has identified a newly emerging adulterant in sports supplements. NSF's John Travis writes about how he and fellow researchers discovered 2-aminoisoheptane in supplements.
NPA says that FDA’s stated goal to crack down on high-risk drugs labeled as homeopathic products is unnecessary given existing regulatory requirements and that the agency should go through formal rulemaking, not draft guidance, if it wishes to enact stricter regulations for homeopathics.
FDA called for public comments on the international drug scheduling of cannabis and cannabis-related substances in preparation for a meeting of the World Health Organization. In response, herbal experts and industry leaders urged the agency not to classify cannabis substances as Schedule I drugs.
Nutritional Outlook interviewed Duffy MacKay, ND, senior vice president, scientific and regulatory affairs, Council for Responsible Nutrition, about some of the biggest regulatory hurdles and ingredients to watch in the sports nutrition category.
Nutritional Outlook interviewed hemp cannabidiol (CBD) firm CV Sciences about the growing market for CBD supplements.
The new Laboratory Guidance Document from the nonprofit ABC-AHP-NCNPR Botanical Adulterants Prevention Program (BAPP) examines several common pomegranate adulteration methods, including diluting those juices and extracts with lower-cost fruit juices or adding ellagic acid from non-pomegranate sources, as well as methods for detecting adulteration in pomegranate juices and extracts.
The SARMs Control Act of 2018 introduced yesterday by Senators Orrin Hatch (R-UT) and Sheldon Whitehouse (D-RI) would add SARMs to the DEA’s list of Schedule III drugs and ensure that SARMs are regulated similarly to anabolic steroids.
Even as regulators seek a more streamlined process for supplements in China, investors, retailers, and customers continue to focus on cross-border e-commerce.
Sabinsa announced that in April, the United States District Court in New Jersey awarded the company $850,000 in damages, ruling that Olive Lifesciences infringed on Sabinsa’s patent covering novel methods and formulations for producing tetrahydrocurcuminoids.
BioCell’s flagship ingredient, BioCell Collagen, has received halal certifications from the Islamic Society of the Washington Area (ISWA) and Halal Quality Control in Germany.
Pure or highly concentrated caffeine powders and liquids are dangerous to consumers when sold in bulk packaging, the agency says.
If the bipartisan Hemp Farming Act of 2018 passes, industrial hemp, as well as hemp CBD, will be regulated like a regular agricultural crop and will no longer be listed on Schedule I of the Controlled Substances Act.
Ingredients supplier Sabinsa has named analytic testing firm Eurofins as its global testing partner for both raw materials and ingredients. Eurofins will also adapt some of Sabinsa’s own proprietary testing methods.
A look at the science behind folic acid, and why it’s relevant.
NSF says that its new DNA Authenticated mark will enable suppliers “to verify the identity and purity of raw ingredients.”
